TORRENT PHARMACEUTICALS
|
The Current P/S Ratio of TORRENT PHARMACEUTICALS is 10.50.
| Share Price | ₹3,801.7 | Dec 04,2025 |
| Market Cap | ₹128,647.8 Cr | |
| Sales-TTM | ₹12,248.0 Cr | TTM-Consolidated Results |
| Price/Sales | 10.50x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹128,647.8 Cr] as on Dec 04,2025
(/) Sales [ ₹12,248.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 10.50x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '10.50 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS
PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.81x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 5.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 9.51x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 5.37x.
How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TORRENT PHARMACEUTICALS | 12,248.0 | 10.50 | 128,647.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.94 | 436,343.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.13 | 171,774.0 |
| CIPLA LTD | 28,349.6 | 4.33 | 122,878.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.11 | 106,581.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.71 | 91,161.8 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.84 | 94,103.0 |
| LUPIN LTD | 24,750.7 | 3.86 | 95,552.4 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.19 | 71,069.8 |
| ABBOTT INDIA LTD | 6,714.4 | 9.12 | 61,255.0 |
| ALKEM LABORATORIES LTD | 13,890.2 | 4.83 | 67,095.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.19x |
| Max industry PS | 17.13x |
| Median industry PS | 4.83x |
| Average industry PS | 6.69x |
You may also like the below Video Courses